|
Alzheimer Disease
Citations 61-70 of 489 total displayed.
|
Past content
(since Jan 1998):
|
- Original Contributions
Assessment of β-Amyloid in a Frontal Cortical Brain Biopsy Specimen and by Positron Emission Tomography With Carbon 11–Labeled Pittsburgh Compound B
- Ville Leinonen; Irina Alafuzoff; Sargo Aalto; Timo Suotunen; Sakari Savolainen; Kjell Någren; Tero Tapiola; Tuula Pirttilä; Jaakko Rinne; Juha E. Jääskeläinen; Hilkka Soininen; Juha O. Rinne
Arch Neurol 65.10.noc80013.
[Abstract]
[Full text]
[]
- Clinical Trials
Phase 2 Safety Trial Targeting Amyloid β Production With a  -Secretase Inhibitor in Alzheimer Disease
- Adam S. Fleisher; Rema Raman; Eric R. Siemers; Lida Becerra; Christopher M. Clark; Robert A. Dean; Martin R. Farlow; James E. Galvin; Elaine R. Peskind; Joseph F. Quinn; Abdullah Sherzai; B. Brooke Sowell; Paul S. Aisen; Leon J. Thal
Arch Neurol 2008; 65: 1031-1038.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Staging Dementia Using Clinical Dementia Rating Scale Sum of Boxes Scores: A Texas Alzheimer's Research Consortium Study
- Sid E. O’Bryant; Stephen C. Waring; C. Munro Cullum; James Hall; Laura Lacritz; Paul J. Massman; Philip J. Lupo; Joan S. Reisch; Rachelle Doody; for the Texas Alzheimer's Research Consortium
Arch Neurol 2008; 65: 1091-1095.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Elevated Cerebrospinal Fluid BACE1 Activity in Incipient Alzheimer Disease
- Henrik Zetterberg; Ulf Andreasson; Oskar Hansson; Guoxin Wu; Sethu Sankaranarayanan; Malin E. Andersson; Peder Buchhave; Elisabet Londos; Robert M. Umek; Lennart Minthon; Adam J. Simon; Kaj Blennow
Arch Neurol 2008; 65: 1102-1107.
[Abstract]
[Full text]
[PDF]
- Editorials
Abeta Predictor of Alzheimer Disease Symptoms
- Chantelle F. Sephton; Gang Yu
Arch Neurol 2008; 65: 875-876.
[Extract]
[Full text]
[PDF]
- Clinical Trials
Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): Results of a Randomized, Controlled Trial of Naproxen and Celecoxib
- ADAPT Research Group
Arch Neurol 2008; 65: 896-905.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Distinct Pools of β-Amyloid in Alzheimer Disease–Affected Brain: A Clinicopathologic Study
- Joshua R. Steinerman; Michael Irizarry; Nikolaos Scarmeas; Susan Raju; Jason Brandt; Marilyn Albert; Deborah Blacker; Bradley Hyman; Yaakov Stern
Arch Neurol 2008; 65: 906-912.
[Abstract]
[Full text]
[PDF]
- Correspondence
Hypertension and Mild Cognitive Impairment Subtypes
- Francesco Panza; Cristiano Capurso; Alessia D’Introno; Anna M. Colacicco; Andrea Santamato; Antonio Capurso; Vincenzo Solfrizzi
Arch Neurol 2008; 65: 992-b-993-b.
[Extract]
[Full text]
[PDF]
- Correspondence
Notice of Failure to Disclose Financial Interest: "A Neuropsychological Test Battery for Use in Alzheimer Disease Clinical Trials" (Arch Neurol. 2007;64[9]:1323-1329)
- John Harrison
Arch Neurol 2008; 65: 992-a.
[Extract]
[Full text]
[PDF]
[ Original Article ]
- Correspondence
Antihypertensive Medications Influence the Rate of Conversion From Mild Cognitive Impairment to Alzheimer Disease
- Luca Rozzini; Barbara Vicini Chilovi; Marco Trabucchi; Alessandro Padovani
Arch Neurol 2008; 65: 993-994.
[Extract]
[Full text]
[PDF]
|
|
